Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus with Reduced CNI in Pediatric Renal Transplant
NCT01544491Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2012
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of everolimus in kidney transplant rejection, sponsored by Novartis. Started Aug 2012; status: completed.
02
Drugs
everolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01544491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01544491.